| Literature DB >> 31979302 |
Elisa Fiume1,2,3, Carla Migneco1, Enrica Verné1,3,4, Francesco Baino1,3,4.
Abstract
Bioactive sol-gel glasses are attractive biomaterials from both technological and functional viewpoints as they require lower processing temperatures compared to their melt-derived counterparts and exhibit a high specific surface area due to inherent nanoporosity. However, most of these materials are based on relatively simple binary or ternary oxide systems since the synthesis of multicomponent glasses via sol-gel still is a challenge. This work reports for the first time the production and characterization of sol-gel materials based on a six-oxide basic system (SiO2-P2O5-CaO-MgO-Na2O-K2O). It was shown that calcination played a role in inducing the formation of crystalline phases, thus generating glass-ceramic materials. The thermal, microstructural and textural properties, as well as the in vitro bioactivity, of these sol-gel materials were assessed and compared to those of the melt-derived counterpart glass with the same nominal composition. In spite of their glass-ceramic nature, these materials retained an excellent apatite-forming ability, which is key in bone repair applications.Entities:
Keywords: bioactive glass; bioactivity; bioceramics; biomaterials; bone tissue engineering; glass-ceramic; nanomaterials; porosity; sol-gel; textural properties
Year: 2020 PMID: 31979302 PMCID: PMC7040641 DOI: 10.3390/ma13030540
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Figure 1Heating programs used for the calcination of DG-120 at Ts1 = 625 °C (a) and Ts2 = 800 °C (b). Intermediate dwelling times and final calcination temperatures were identified on the basis of the differential thermal analysis results.
Figure 2Thermal analysis results: DTA plot of MD-47.5B bioactive glass (a) and DTA-TGA plots of DG-120 sol-gel material before calcination, revealing a multi-peak trend and mass loss up to 800 °C (b).
Figure 3XRD pattern evolution upon thermal treatment of sol-gel 47.5B system at different stages of the synthesis process: DG-120 (a), SG-625 (b) and SG-800 (c).
Crystalline phases detected in SG-625 and SG-800 sol-gel materials.
| Detected in: | Phase Name | Reference Code | Formula | Crystal System |
|---|---|---|---|---|
| SG-625 | Niter | 01-071-1558 | KNO3 | Orthorhombic |
| Nitratine | 00-036-1474 | NaNO3 | Rhombohedral | |
| SG-800 | Sodium calcium silicate (combeite-type) | 01-077-2189 | Na2CaSi2O6 | Rhombohedral |
| Potassium magnesium silicate | 00-048-0900 | K2MgSiO4 | Orthorhombic | |
| Rhenanite | 00-029-1193 | NaCaPO4 | Orthorhombic |
Figure 4SEM morphological evaluation of DG-120 (a–c), SG-625 (d–f) and SG-800 (g–i) sol-gel-derived powders at different magnifications.
Figure 5EDS compositional analysis performed on DG-120 (a), SG-625 (b) and SG-800 (c) sol-gel materials.
Brunauer–Emmett–Teller (BET) analysis results.
| Material | Class | Calcination Temperature (°C) | SSA (m2/g) | Pore Volume (cm3/g) |
|---|---|---|---|---|
| MD-47.5B | Glass | As-quenched | 0.6379 | 0.001304 |
| SG-625 | Glass-ceramic | 625 | 2.2330 | 0.016708 |
| SG-800 | Glass-ceramic | 800 | 1.2307 | 0.002727 |
Figure 6In vitro bioactivity tests: pH increase as a function of the soaking time in simulated body fluid (SBF).
Figure 7In vitro bioactivity tests: SEM analysis showing the surface evolution at different immersion time periods in SBF.